
Board Meeting6 Jun 2026, 07:21 pm
Gujarat Themis Biosyn Plans ₹1000 Cr Fund Raise via QIP/Preferential Issue
AI Summary
Gujarat Themis Biosyn Ltd's Board of Directors has approved a plan to raise up to ₹1,000 Crores through a Qualified Institutions Placement (QIP) and/or preferential issue. The funds will be raised through public and/or private offerings of equity shares and/or convertible securities. The decision is subject to shareholder and regulatory approvals. The company also plans a preferential issue of equity shares to non-promoters. Further details regarding the number of securities, issue price, and investors will be decided by the Fund-Raising Committee and disclosed in due course.
Key Highlights
- Board approves raising up to ₹1,000 Crores.
- Fundraising via QIP and/or preferential issue.
- Subject to shareholder and regulatory approvals.
- Details on investors and pricing to be announced later.